Efficacy of Valerian Root Extract on Anxiety via Bioinformatics

Document Type : Original paper


1 Traditional Medicine and Materia Medica Research Center, Department of Traditional Pharmacy, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

2 Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

3 Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

4 Physiotherapy Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.


Background and objectives: Treatment with root extract of valerian can reduce anxiety neurosis symptoms. To investigate the related therapeutic impacts, bioinformatics analysis of proteome profile of rat’s hippocampus tissue was carried out. Methods: Cytoscape V.3.9.1, and its plug-ins were applied for the construction of protein-protein interaction network of the treated subjects. NetworkAnalyzer and ClueGO+CuePedia were used to study centrality and gene ontology of the protein-protein interaction (PPI) network. Results: Results indicated that seven central proteins Actb, Alb, Akt1, Egfr, Tp53 as hub-bottlenecks and Th and H2afx as hub and bottleneck differentially expressed proteins (DEPs) are present in the PPI network and four corresponding biological processes. Among these seven proteins, two including tyrosine 3-monooxygenase (Th) and Histone H2A (H2afx) are differentially expressed proteins in the exposure of valerian. Conclusion: It was found that the histone H2A and tyrosine 3-monooxygenase as central nodes are the main targets of valerian which are associated with anti-anxiety effects of the herb.   


Main Subjects

  • Nunes A, Sousa M. Use of valerian in anxiety and sleep disorders: what is the best evidence? Acta Med Port. 2011; 24(S4): 961–966.
  • Rostami-Nejad M, Taraghikhah N, Ciacci C, Pourhoseingholi MA, Barzegar F, Rezaei-Tavirani M, Aldulaimi D, Zali Anxiety symptoms in adult celiac patients and the effect of a gluten-free diet: an Iranian nationwide study. Inflamm Intest Dis. 2020; 5(1): 42–48.
  • Carpenter JK, Andrews LA, Witcraft SM, Powers MB, Smits JA, Hofmann SG. Cognitive behavioral therapy for anxiety and related disorders: a meta‐analysis of randomized placebo‐controlled trials. Depress Anxiety. 2018; 35(6): 502–514.
  • Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, Iosifescu Pharmacotherapy of anxiety disorders: current and emerging treatment options. Front Psychiatry. 2020: 11: 1–21.
  • Ravindran LN, Stein MB. The pharmacologic treatment of anxiety disorders: a review of progress. J Clin Psychiatry. 2010; 71(7): 839–854.
  • Sayed AM, Morsy S, Tawfik GM, Naveed S, Minh-Duc NT, Hieu TH, Ali ZA, Shinkar A, Fahmy Doheim M, Rashidul Hashan M, Tien Huy The best route of administration of lavender for anxiety: a systematic review and network meta-analysis. Gen Hosp Psychiatry. 2020; 64: 33–40.
  • Shahrajabian MH, Sun W, Soleymani A, Cheng Q. Traditional herbal medicines to overcome stress, anxiety and improve mental health in outbreaks of human coronaviruses. Phytother Res. 2021; 35(3): 1237–1247.
  • Shinjyo N, Waddell G, Green J. Valerian root in treating sleep problems and associated disorders, a systematic review and meta-analysis. J Evid Based Integr Med. 2020; 25: 1–31.
  • Wang SN, Yao ZW, Zhao CB, Ding YS, Bian LH, Li QY, Wang XM, Shi JL, Guo JY, Wang Discovery and proteomics analysis of effective compounds in Valeriana jatamansi Jones for the treatment of anxiety. J Ethnopharmacol. 2021; 265: 1–12.
  • Shankar P, Priya J, Devi G, Arivarasu L. Effects of valerian root on menstrual disorders. Ann Roman Soc Cell Biol. 2021; 25(2): 2675–2684.
  • Choi HS, Hong KB, Han SH, Suh HJ. Valerian/Cascade mixture promotes sleep by increasing non-rapid eye movement (NREM) in rodent model. Biomed Pharmacother. 2018; 99: 913–920.
  • Orhan IE. A review focused on molecular mechanisms of anxiolytic effect of Valerina officinalis in connection with its phytochemistry through in vitro/in vivo studies. Curr Pharm Des. 2021; 27(28): 3084–3090.
  • Benke D, Barberis A, Kopp S, Altmann KH, Schubiger M, Vogt KE, Rudolph U, Möhler GABAA receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology. 2009; 56(1): 174–181.
  • Hoban CL, Byard RW, Musgrave IF. Analysis of spontaneous adverse drug reactions to echinacea, valerian, black cohosh and ginkgo in Australia from 2000 to 2015. J Integr Med. 2019; 17(5): 338–343.
  • Freitas C, Khanal S, Landsberg D, Kaul V. An alternative cause of encephalopathy: valerian root overdose. Cureus. 2021; 13(9): 1–4.
  • Dalla Corte C, Fachinetto R, Colle D, Pereira R, Avila D, Villarinho J, Wagner C, Pereira M, Nogueira C, Soares F, Rocha Potentially adverse interactions between haloperidol and valerian. Food Chem Toxicol. 2008; 46(7): 2369–2375.
  • Chen JJ, Bai SJ, Li WW, Zhou CJ, Zheng P, Fang L, Wang HY, Liu YY, Xie Urinary biomarker panel for diagnosing patients with depression and anxiety disorders. Transl Psychiatry. 2018; 8(1): 1–10.
  • Chojnowska S, Ptaszyńska-Sarosiek I, Kępka A, Knaś M, Waszkiewicz N. Salivary biomarkers of stress, anxiety and depression. J Clin Med. 2021; 10(3): 1–12.
  • Azodi MZ, Rezaei-Tavirani M, Nejad MR, Arjmand B, Razzaghi M. Uncovering systemic lupus erythematosus candidate proteomic biomarkers: a bioinformatics approach. J Cell Mol Anesth. 2022; 7(1): 40–48.
  • Arjmand B, Zamanian Azodi M, Rezaei Tavirani M, Khodadoost M, Rostami Nejad M, Ahmadi N. Tumorigenesis inhibition of carnosol from rosemary: an insight to molecular targeting. Res J Pharmacogn. 2022; 9(1): 103–110.
  • Rezaei-Tavirani M, Rezaei-Tavirani S, Mansouri V, Rostami-Nejad M, Rezaei-Tavirani M. Protein-protein interaction network analysis for a biomarker panel related to human esophageal adenocarcinoma. Asian Pac J Cancer Prev. 2017; 18(12): 3357–3363.
  • Assenov Y, Ramírez F, Schelhorn SE, Lengauer T, Albrecht M. Computing topological parameters of biological networks. Bioinformatics. 2008; 24(2): 282–284.
  • Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape stringapp: network analysis and visualization of proteomics data. J Proteome Res. 2018; 18(2): 623–632.
  • Bindea G, Galon J, Mlecnik B. Cluepedia cytoscape plugin: pathway insights using integrated experimental and in silico data. Bioinformatics. 2013; 29(5): 661–663.
  • Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, Fridman WH, Pagès F, Trajanoski Z, Galon ClueGO: a cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009; 25(8): 1091–1093.
  • Roh D, Jung JH, Yoon KH, Lee CH, Kang LY, Lee SK, Shin K, Kim DH. Valerian extract alters functional brain connectivity: a randomized double‐blind placebo‐controlled trial. Phytother Res. 2019; 33(4): 939–948.
  • Peyvandi H, Peyvandi AA, Safaei A, Azodi MZ, Rezaei-Tavirani M. Introducing potential key proteins and pathways in human laryngeal cancer: a system biology approach. Iran J Pharm Res. 2018; 17(1): 415–425.
  • Munkholm K, Peijs L, Vinberg M, Kessing L. A composite peripheral blood gene expression measure as a potential diagnostic biomarker in bipolar disorder. Transl Psychiatry. 2015; 5(8): 1–10.
  • Azodi MZ, Tavirani MR, Tavirani MR. Identification of the key genes of autism spectrum disorder through protein-protein interaction network. Galen Med J. 2019; 8: 1–8.
  • Stones A, Groome DH, Clow A, Hucklebridge F. Raised blood albumin levels are associated with trait anxiety. Depress Anxiety. 1997; 4(3): 151–152.
  • Yang C, Sun N, Ren Y, Sun Y, Xu Y, Li A, Wu K, Zhang Association between AKT1 gene polymorphisms and depressive symptoms in the Chinese Han population with major depressive disorder. Neural Regen Res. 2012; 7(3): 235–239.
  • McFarland DC, Jutagir DR, Rosenfeld B, Pirl W, Miller AH, Breitbart W, Nelson Depression and inflammation among epidermal growth factor receptor (EGFR) mutant nonsmall cell lung cancer patients. Psychooncology. 2019; 28(7): 1461–1469.
  • Yang J, Wu X, Huang J, Chen Z, Huang G, Guo X, Zhu L, Su TP53 polymorphism contributes to the susceptibility to bipolar disorder but not to schizophrenia in the Chinese Han population. J Mol Neurosci. 2019; 68(4): 679–687.
  • Suri D, Bhattacharya A, Vaidya VA. Early stress evokes temporally distinct consequences on the hippocampal transcriptome, anxiety and cognitive behaviour. Int J Neuropsychopharmacol. 2014; 17(2): 289–301.
  • Weyemi U, Paul BD, Snowman AM, Jailwala P, Nussenzweig A, Bonner WM, Snyder Histone H2AX deficiency causes neurobehavioral deficits and impaired redox homeostasis. Nat Commun. 2018; 9(1): 1–10.
  • Shen T, Ji F, Wang Y, Lei X, Zhang D, Jiao J. Brain-specific deletion of histone variant H2A. z results in cortical neurogenesis defects and neurodevelopmental disorder. Nucleic Acids Res. 2018; 46(5): 2290–2307.
  • Serretti A, Macciardi F, Verga M, Cusin C, Pedrini S, Smeraldi E. Tyrosine hydroxylase gene associated with depressive symptomatology in mood disorder. Am J Med Genet. 1998; 81(2): 127–130.
  • Sridharan S, Mohankumar K, Jeepipalli SPK, Sankaramourthy D, Ronsard L, Subramanian K, Thamilarasan M, Raja K, Chandra VK, Sadras Neuroprotective effect of Valeriana wallichii rhizome extract against the neurotoxin MPTP in C57BL/6 mice. Neurotoxicology. 2015; 51: 172–183.